Heartflow, a healthcare company, reported a wider quarterly loss of $32.3 million compared to $20.9 million last year. The IPO filing showed revenue of $37.2 million for the quarter, up from $26.8 million a year ago. The company plans to use IPO proceeds for debt payment, sales, marketing, research, and development. It develops an AI-powered heart imaging tool to improve diagnosis and treatment. Heartflow will list on Nasdaq under “HTFL” with underwriters including J.P. Morgan and Morgan Stanley.

Read more at Yahoo Finance: Healthcare firm Heartflow’s IPO filing discloses wider loss